The Ecstasy and Agony of Assay Interference Compounds.
作者信息
Aldrich Courtney, Bertozzi Carolyn, Georg Gunda I, Kiessling Laura, Lindsley Craig, Liotta Dennis, Merz Kenneth M, Schepartz Alanna, Wang Shaomeng
机构信息
ACS Infectious Diseases.
ACS Central Science.
出版信息
ACS Med Chem Lett. 2017 Feb 28;8(4):379-382. doi: 10.1021/acsmedchemlett.7b00056. eCollection 2017 Apr 13.
Abstract
摘要
相似文献
1
The Ecstasy and Agony of Assay Interference Compounds.
ACS Med Chem Lett. 2017 Feb 28;8(4):379-382. doi: 10.1021/acsmedchemlett.7b00056. eCollection 2017 Apr 13.
2
Eroticism in group psychotherapy: psychoanalytic reflections on desire, agony, and ecstasy.
Int J Group Psychother. 2003 Oct;53(4):443-57. doi: 10.1521/ijgp.53.4.443.42831.
3
Comment on The Ecstasy and Agony of Assay Interference Compounds.
J Chem Inf Model. 2017 Nov 27;57(11):2640-2645. doi: 10.1021/acs.jcim.7b00313. Epub 2017 Nov 7.
4
The Ecstasy and Agony of Assay Interference Compounds.
ACS Cent Sci. 2017 Mar 22;3(3):143-147. doi: 10.1021/acscentsci.7b00069. Epub 2017 Feb 28.
5
The Ecstasy and Agony of Assay Interference Compounds.
ACS Infect Dis. 2017 Apr 14;3(4):259-262. doi: 10.1021/acsinfecdis.7b00023. Epub 2017 Feb 28.
6
The Ecstasy and Agony of Assay Interference Compounds.
ACS Chem Biol. 2017 Mar 17;12(3):575-578. doi: 10.1021/acschembio.7b00119. Epub 2017 Feb 28.
7
The Ecstasy and Agony of Assay Interference Compounds.
Biochemistry. 2017 Mar 14;56(10):1363-1366. doi: 10.1021/acs.biochem.7b00110. Epub 2017 Feb 28.
8
The Ecstasy and Agony of Assay Interference Compounds.
ACS Chem Neurosci. 2017 Mar 15;8(3):420-423. doi: 10.1021/acschemneuro.7b00064. Epub 2017 Feb 28.
9
The Ecstasy and Agony of Assay Interference Compounds.
J Chem Inf Model. 2017 Mar 27;57(3):387-390. doi: 10.1021/acs.jcim.7b00105. Epub 2017 Feb 28.
10
The Ecstasy and Agony of Assay Interference Compounds.
J Med Chem. 2017 Mar 23;60(6):2165-2168. doi: 10.1021/acs.jmedchem.7b00229. Epub 2017 Feb 28.
引用本文的文献
1
How Should we Teach Medicinal Chemistry in Higher Education to Prepare Students for a Future Career as Medicinal Chemists and Drug Designers? - A Teacher's Perspective.
ChemMedChem. 2025 Jan 14;20(2):e202400791. doi: 10.1002/cmdc.202400791. Epub 2024 Nov 20.
2
Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease.
Pharmaceuticals (Basel). 2022 Dec 23;16(1):20. doi: 10.3390/ph16010020.
3
Dual Targeting of MDM4 and FTH1 by MMRi71 for Induced Protein Degradation and p53-Independent Apoptosis in Leukemia Cells.
Molecules. 2022 Nov 8;27(22):7665. doi: 10.3390/molecules27227665.
4
Covalent sortase A inhibitor ML346 prevents infection of .
RSC Med Chem. 2021 Nov 1;13(2):138-149. doi: 10.1039/d1md00316j. eCollection 2022 Feb 23.
5
Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays.
Viruses. 2021 Dec 31;14(1):69. doi: 10.3390/v14010069.
6
1,2-Naphthoquinone-4-sulfonic acid salts in organic synthesis.
Beilstein J Org Chem. 2022 Jan 5;18:53-69. doi: 10.3762/bjoc.18.5. eCollection 2022.
7
Inhibitors of HIV-1 Nef-Mediated Activation of the Myeloid Src-Family Kinase Hck Block HIV-1 Replication in Macrophages and Disrupt MHC-I Downregulation.
ACS Infect Dis. 2022 Jan 14;8(1):91-105. doi: 10.1021/acsinfecdis.1c00288. Epub 2022 Jan 5.
8
A Dual-Specificity Inhibitor Targets Polyphosphate Kinase 1 and 2 Enzymes To Attenuate Virulence of Pseudomonas aeruginosa.
mBio. 2021 Jun 29;12(3):e0059221. doi: 10.1128/mBio.00592-21. Epub 2021 Jun 15.
9
Novel Immune Modulators Enhance Resistance to Multiple Pathogens.
mSphere. 2021 Jan 6;6(1):e00950-20. doi: 10.1128/mSphere.00950-20.
10
Chemoinformatic Database Building and in Silico Hit-Identification of Potential Multi-Targeting Bioactive Compounds Extracted from Mushroom Species.
Molecules. 2017 Sep 19;22(9):1571. doi: 10.3390/molecules22091571.
本文引用的文献
1
Discovery of a Selective Aurora A Kinase Inhibitor by Virtual Screening.
J Med Chem. 2016 Aug 11;59(15):7188-211. doi: 10.1021/acs.jmedchem.6b00709. Epub 2016 Jul 20.
2
Badapple: promiscuity patterns from noisy evidence.
J Cheminform. 2016 May 28;8:29. doi: 10.1186/s13321-016-0137-3. eCollection 2016.
3
Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS).
J Nat Prod. 2016 Mar 25;79(3):616-28. doi: 10.1021/acs.jnatprod.5b00947. Epub 2016 Feb 22.
4
Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery?
J Med Chem. 2016 Mar 10;59(5):1671-90. doi: 10.1021/acs.jmedchem.5b01009. Epub 2015 Oct 27.
5
How to Triage PAINS-Full Research.
Assay Drug Dev Technol. 2016 Apr;14(3):168-74. doi: 10.1089/adt.2015.674. Epub 2015 Oct 23.
6
Docking studies on the interaction of flavonoids with fat mass and obesity associated protein.
Pak J Pharm Sci. 2015 Sep;28(5):1647-53.
7
Pan Assay Interference Compounds (PAINS) and Other Promiscuous Compounds in Antifungal Research.
J Med Chem. 2016 Jan 28;59(2):497-503. doi: 10.1021/acs.jmedchem.5b00361. Epub 2015 Sep 8.
8
An Aggregation Advisor for Ligand Discovery.
J Med Chem. 2015 Sep 10;58(17):7076-87. doi: 10.1021/acs.jmedchem.5b01105. Epub 2015 Aug 28.
9
The promise and peril of chemical probes.
Nat Chem Biol. 2015 Aug;11(8):536-41. doi: 10.1038/nchembio.1867.
10
Novel Broad Spectrum Inhibitors Targeting the Flavivirus Methyltransferase.
PLoS One. 2015 Jun 22;10(6):e0130062. doi: 10.1371/journal.pone.0130062. eCollection 2015.
Zotero 插件